Search -

Displaying 1 - 20 of 73

Sort: Relevancy | Date

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

L.A. McKeown

June 12, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

Caitlin E. Cox

February 22, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Todd Neale

January 18, 2023

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Todd Neale

August 02, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

Advertisement

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

ACC: It’s Time for Clinicians to Address Inflammation in CVD

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Niacin, When Broken Down by the Body, Can Spur Inflammation

Top General Cardiology and CVD Prevention News of 2023

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Acute MI, Stroke Risks Rise in the Months After Gout Flares

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content